Company overview
Relmada Therapeutics, Inc. operates as a clinical-stage biotechnology company in the United States. The company focuses on the development of NDV-01, a controlled-release intravesical formulation of gemcitabine and docetaxel, which is in Phase 2 clinical trial for patients with aggressive forms of non-muscle invasive bladder cancer; and sepranolone, a neurosteroid epimer of allopregnanolone, which is Phase 2b-ready for the potential treatment of Prader-Willi Syndrome, Tourette Syndrome, excessive tremor, and other diseases related to excessive GABAergic activity. It also develops REL-P11, a modified-release formulation of psilocybin that has completed Phase 1 safety study for the treatment of metabolic disease. Relmada Therapeutics, Inc. was founded in 2004 and is headquartered in Coral Gables, Florida.
Daily valuation snapshot
These values come from the daily market snapshot dated 2026-10-08. TTM means trailing twelve months. Use the market date when comparing RLMD with another company.
| Daily close (USD) | $3.17 |
| Market capitalization (USD) | $338,143,411.82 |
| Price / earnings (TTM) | Not reported |
| Price / book | 1.64 |
No matching rows. Clear the filter to see all records.
Read RLMD's valuation metrics
Company size
Relmada Therapeutics, Inc. Common Stock's recorded market capitalization is $338,143,411.82. It measures the market value of the company's equity, rather than its revenue or cash balance.
Price relative to earnings
P/E compares share price with trailing annual earnings per share. For a company with losses, inspect the earnings figures directly rather than treating a negative multiple as a cheap valuation.
Price relative to book equity
RLMD's recorded price-to-book ratio is 1.64. That compares its market equity value with recorded book equity. Examine its business and balance sheet to understand why those values differ.
Research Relmada Therapeutics, Inc. Common Stock with Aurora
Use the snapshot above to ask a specific question about RLMD. Ask for the report period and the figures behind the explanation, then compare the answer with the company's business description.
Continue the research
Follow RLMD's ownership disclosures to see who filed a transaction or position and when it became public. To turn a research idea into a strategy, define an entry rule and test its dated observations.